Development of antibody-directed therapies: quo vadis?

© 2018 The Authors. Published by Wiley-VCH Verlag GmbH & Co. KGaA. This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

Bibliographic Details
Main Author: Rodrigues, Tiago (author)
Other Authors: Bernardes, Gonçalo J. L. (author)
Format: article
Language:eng
Published: 2021
Subjects:
Anti-tumor agents
Antibody-drug conjugates
Bioconjugation
Drug delivery
Linkers
Online Access:http://hdl.handle.net/10451/50253
Country:Portugal
Oai:oai:repositorio.ul.pt:10451/50253

Internet

http://hdl.handle.net/10451/50253

Similar Items